Park Avenue Securities LLC Biogen Inc. Transaction History

Park Avenue Securities LLC

$8.9 Billion
Q3 2024

A detailed history of Park Avenue Securities LLC transactions in Biogen Inc. stock. As of the latest transaction made, Park Avenue Securities LLC holds 2,630 shares of BIIB stock, worth $414,119. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,630

Previous 2,529 3.99%

Holding current value

$414,119

Previous $586,000 12.97%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	BUY	$189.07 - $236.8 $19,096 - $23,916	101 Added 3.99%	2,630 $510,000
Q2 2024 Jul 09, 2024	BUY	$190.52 - $236.72 $36,770 - $45,686	193 Added 8.26%	2,529 $586,000
Q1 2024 Apr 10, 2024	SELL	$212.02 - $267.71 $45,584 - $57,557	-215 Reduced 8.43%	2,336 $504,000
Q4 2023 Jan 10, 2024	SELL	$222.59 - $267.94 $62,547 - $75,291	-281 Reduced 9.92%	2,551 $660,000
Q3 2023 Oct 26, 2023	BUY	$253.3 - $285.89 $717,345 - $809,640	2,832 New	2,832 $728,000
Q4 2022 Jan 24, 2023	BUY	$252.44 - $306.72 $57,051 - $69,318	226 Added 15.35%	1,698 $0
Q3 2022 Nov 01, 2022	BUY	$194.69 - $268.46 $32,318 - $44,564	166 Added 12.71%	1,472 $393,000
Q2 2022 Jul 27, 2022	BUY	$187.54 - $223.02 $46,322 - $55,085	247 Added 23.32%	1,306 $266,000
Q1 2022 Apr 29, 2022	BUY	$193.77 - $244.14 $40,497 - $51,025	209 Added 24.59%	1,059 $223,000
Q4 2021 Apr 08, 2022	SELL	$223.92 - $287.77 $97,629 - $125,467	-436 Reduced 33.9%	850 $203,000
Q3 2021 Oct 21, 2021	BUY	$282.99 - $369.05 $15,564 - $20,297	55 Added 4.47%	1,286 $364,000
Q2 2021 Aug 05, 2021	SELL	$259.0 - $414.71 $69,153 - $110,727	-267 Reduced 17.82%	1,231 $426,000
Q1 2021 Apr 28, 2021	BUY	$242.95 - $284.63 $68,026 - $79,696	280 Added 22.99%	1,498 $419,000
Q4 2020 Jan 20, 2021	SELL	$236.26 - $355.63 $176,249 - $265,299	-746 Reduced 37.98%	1,218 $298,000
Q3 2020 Nov 03, 2020	BUY	$264.77 - $305.71 $22,505 - $25,985	85 Added 4.52%	1,964 $557,000
Q2 2020 Jul 30, 2020	BUY	$258.66 - $342.55 $83,547 - $110,643	323 Added 20.76%	1,879 $503,000
Q1 2020 Apr 28, 2020	BUY	$268.85 - $341.04 $138,457 - $175,635	515 Added 49.47%	1,556 $492,000
Q4 2019 Feb 04, 2020	BUY	$220.06 - $304.07 $21,785 - $30,102	99 Added 10.51%	1,041 $309,000
Q3 2019 Oct 18, 2019	BUY	$217.44 - $243.88 $8,480 - $9,511	39 Added 4.32%	942 $219,000
Q2 2019 Jul 26, 2019	SELL	$219.29 - $241.72 $17,323 - $19,095	-79 Reduced 8.04%	903 $211,000
Q1 2019 May 02, 2019	SELL	$216.71 - $338.96 $6,934 - $10,846	-32 Reduced 3.16%	982 $228,000
Q4 2018 Jan 29, 2019	BUY	$278.5 - $352.75 $108,058 - $136,867	388 Added 61.98%	1,014 $338,000
Q3 2018 Nov 05, 2018	BUY	$293.51 - $383.83 $183,737 - $240,277	626 New	626 $221,000

Others Institutions Holding BIIB

# of Institutions

1,038

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Park Avenue Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Park Avenue Securities LLC with notifications on news.

Account

Park Avenue Securities LLC Biogen Inc. Transaction History